Supported by a grant from the NIH, researchers from Weill Cornell Medicine and the University of Miami will study ways to use wastewater as an early warning and mapping system for genetic variants of the virus that causes COVID-19.
A $30 million commitment from David R. Atkinson ’60 and Patricia Atkinson will name a new multidisciplinary building on campus, intended to foster innovative and collaborative research in key university priority areas.
The Office of Academic Integration has awarded $750,000 in seed grants to 10 studies ranging from refugee health and legal rights, to a vaccine treating fentanyl addiction and overdose, to pancreatic cancer and antibiotic tolerance.
Marla Beyer, MBA/MHA ’20, hopscotched over more than 60 student teams from the U.S. and Ireland to win the $25,000 first prize at this year’s Blackstone LaunchPad’s Startup Grind Pitch Competition.
In an expansion of its biomedical education curricula, Weill Cornell Medicine is launching an additional site for graduate programs at Houston Methodist for the 2021-22 academic year.
Future pandemics can be averted if the world’s governments eliminate unnecessary wildlife trade and adopt holistic approaches, according to experts at a Feb. 23 virtual conference.
Doctoral students Rob Swanda and Juliana González-Tobón have taken the internet by storm with their videos that take some of the mystery out of the COVID-19 vaccines.
A new study identifies the mechanism for tolerance to penicillin and related antibiotics in bacteria, findings that could lead to new therapies that boost the effectiveness of these treatments.
